Comment on

• Clinical experience with a 39 mmol/L bicarbonate-buffered peritoneal dialysis solution.

  Feriani M, Carobi C, La Greca G, Buoncristiani U, Passlick-Deetjen J. Feriani M, et al. Perit Dial Int. 1997 Jan-Feb;17(1):17-21. Perit Dial Int. 1997. PMID: 9068017 Clinical Trial.
• Icodextrin: overview of clinical experience.

  Peers E, Gokal R. Peers E, et al. Perit Dial Int. 1997 Jan-Feb;17(1):22-6. Perit Dial Int. 1997. PMID: 9068018 Review.
• Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis.

  Rippe B, Simonsen O, Wieslander A, Landgren C. Rippe B, et al. Perit Dial Int. 1997 Jan-Feb;17(1):27-34. Perit Dial Int. 1997. PMID: 9068019
• Icodextrin's effects on peritoneal transport.

  Krediet RT, Ho-dac-Pannekeet MM, Imholz AL, Struijk DG. Krediet RT, et al. Perit Dial Int. 1997 Jan-Feb;17(1):35-41. Perit Dial Int. 1997. PMID: 9068020 Review.
• A randomized controlled trial of a bicarbonate- and a bicarbonate/lactate-containing dialysis solution in CAPD.

  Coles GA, Gokal R, Ogg C, Jani F, O'Donoghue DT, Cancarini GC, Maiorca R, Tranaeus A, Faict D, de Vos C. Coles GA, et al. Perit Dial Int. 1997 Jan-Feb;17(1):48-51. Perit Dial Int. 1997. PMID: 9068022 Clinical Trial.
• Glycation and advanced glycation end-product formation with icodextrin and dextrose.

  Dawnay AB, Millar DJ. Dawnay AB, et al. Perit Dial Int. 1997 Jan-Feb;17(1):52-8. Perit Dial Int. 1997. PMID: 9068023